Laura Tanenbaum

Laura Tanenbaum is a Principal Scientist in the BioTherapeutics Drug Product Development & Delivery group at Janssen R&D with over 5 years of experience in high-concentration formulation development of monoclonal antibodies. Laura received a B.S. in Chemical and Biomolecular Engineering from Rice University and a Ph.D. in Medical Engineering from the Harvard-MIT Health Sciences and Technology Program.